HERBAL EXPECTORANT - CAP DIN 02223430
Health Canada record
| Active ingredient(s) | SCULLCAP 31.25 MG; GLYCYRRHIZA GLABRA 15.63 MG; OPHIOPOGON JAPONICUS 46.88 MG; ASPARAGUS OFFICINALIS 31.25 MG; SCHISANDRA 140.63 MG; APRICOT 31.25 MG; MULBERRY 31.25 MG; ADENOPHORA 39.06 MG; GINGER 39.06 MG; CITRUS RETICULATA 93.75 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 23-Aug-1996 |
| Current status date | 14-Sep-2001 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamieson Laboratories Ltd. — licence 100166, currently licensed, last inspection rating C (2022-05-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SCULLCAP
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00844217 | SCUTELLARIA DPS 1X-C1000 | THOMPSON'S HOMEOPATHIC SUPPLIES LTD. | Drops | SCULLCAP 1 X | Cancelled Post Market |
| 02234119 | SCUTELLARIA LATERIFLORA | HOMEOCAN INC. | Drops; Globules; Granules | SCULLCAP 1 X | Cancelled Post Market |
| 02233205 | SCUTELLARIA LATERIFLORA | SEROYAL INTERNATIONAL INC. | Liquid; Granules; Tablet; Globules; Drops; Pellet | SCULLCAP 1 X | Cancelled Post Market |
| 01953281 | SCUTELLARIA LATERIFLORA GRAN (1CH-30CH) | HOMEOCAN INC. | Tablet | SCULLCAP 1 CH | Cancelled Post Market |
| 02234729 | SCUTELLARIA LATERIFOLIA | DOLISOS CANADA INC. | Globules; Liquid; Granules | SCULLCAP 1 X | Cancelled Post Market |